(0.03%) 5 208.00 points
(0.05%) 39 017 points
(-0.17%) 18 164 points
(-0.51%) $78.08
(-0.55%) $2.18
(-0.35%) $2 323.00
(-0.06%) $27.60
(2.08%) $984.95
(-0.04%) $0.928
(0.26%) $10.85
(0.09%) $0.797
(-0.16%) $91.20
2 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 7.89%
Live Chart Being Loaded With Signals
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital...
Stats | |
---|---|
本日の出来高 | 362 935 |
平均出来高 | 482 428 |
時価総額 | 4.84B |
EPS | $0 ( 2024-02-08 ) |
次の収益日 | ( $0.880 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 38.77 |
ATR14 | $0.0850 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Darecca James | Sell | 432 | Common Stock |
2024-04-15 | Lingamneni Anila | Sell | 184 | Common Stock |
2024-03-11 | Simon, Christopher | Sell | 38 900 | Common Stock |
2023-11-01 | Galvin Roy | Sell | 160 | Common Stock |
2023-10-20 | Basil Michelle L | Sell | 197 | Common Stock |
INSIDER POWER |
---|
-12.57 |
Last 95 transactions |
Buy: 406 848 | Sell: 507 219 |
ボリューム 相関
Haemonetics Corp 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Haemonetics Corp 相関 - 通貨/商品
Haemonetics Corp 財務諸表
Annual | 2023 |
収益: | $1.17B |
総利益: | $615.10M (52.63 %) |
EPS: | $2.27 |
FY | 2023 |
収益: | $1.17B |
総利益: | $615.10M (52.63 %) |
EPS: | $2.27 |
FY | 2023 |
収益: | $1.17B |
総利益: | $615.10M (52.63 %) |
EPS: | $0 |
FY | 2022 |
収益: | $993.20M |
総利益: | $505.50M (50.90 %) |
EPS: | $0.850 |
Financial Reports:
No articles found.
Haemonetics Corp
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。